CDKN1B and lymphoma: SKP2 promotes the degradation of phosphorylated cyclin-dependent kinase inhibitor p27 Kip1[30], and SKP2 overexpression has been shown to contribute to p27Kip1 degradation in lymphomas [31], colorectal cancer [32], and GIST [10].